A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7248824 in Participants With Angelman Syndrome (AS)
Clinical trial NCT04428281 · COMPLETED
Trial details
- NCT number
- NCT04428281
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-19
- Primary completion
- 2025-07-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.